What is the recommended melatonin dosage and administration schedule for adults, older adults, and children?

Melatonin Dosage Recommendations

For adults with delayed sleep-wake phase disorder (DSWPD), use 5 mg of melatonin taken between 19:00-21:00 (7-9 PM) for at least 28 days; for children ages 6-12 without comorbidities, use 0.15 mg/kg (approximately 3-5 mg) taken 1.5-2 hours before habitual bedtime. 1

Adults

Standard dosing for adults:

• Dose: 5 mg daily
• Timing: Between 19:00-21:00 (7-9 PM), NOT at bedtime
• Duration: Minimum 28 days for therapeutic effect 1

The American Academy of Sleep Medicine guidelines provide LOW quality evidence supporting this regimen for adults with DSWPD, with or without comorbid depression 1. While the evidence quality is limited, clinical experience supports frequent acceptance of this treatment versus no intervention.

Important timing consideration: Recent dose-response meta-analysis suggests optimal efficacy may occur when melatonin is administered 3 hours before desired bedtime at 4 mg/day 2. This conflicts somewhat with the guideline recommendation of 19:00-21:00 timing, but both approaches emphasize earlier administration than the commonly misused "30 minutes before bed" pattern.

Common Pitfall - Timing Error

Most patients take melatonin 30 minutes before bed, which is incorrect. Melatonin works by phase-shifting circadian rhythms, not as a sedative-hypnotic. It requires 1.5-3 hours lead time before the desired sleep period to be effective.

Children and Adolescents (Ages 6-12)

Without Psychiatric Comorbidities

The evidence here is MODERATE quality - the strongest in all melatonin literature 1:

• Dose: 0.15 mg/kg (optimal dose from dose-ranging study)
  • This translates to approximately 1.6-4.4 mg depending on weight
  • Mean effective dose was 4.4 ± 1.0 mg
• Timing: 1.5-2.0 hours before habitual bedtime
• Duration: Effective within 6 nights 1

With Psychiatric Comorbidities (especially ADHD)

Evidence quality is LOW 1:

• Dose: Weight-based dosing
  • 3 mg if <40 kg
  • 5 mg if ≥40 kg
• Timing: 18:00-19:00 (6-7 PM)
• Formulation: Fast-release melatonin specifically
• Duration: 4 weeks minimum 1

This regimen advanced sleep onset by approximately 37 minutes and shifted circadian phase (DLMO) by nearly 1 hour 1.

Special Populations - Autism Spectrum Disorder

For children with ASD and sleep problems 3:

• Starting dose: 1 mg fast-release
• Maximum dose: 4 mg
• Timing: 30-40 minutes before bedtime
• Titration: Increase by 1 mg every 2 weeks if no response, up to 6 mg maximum

Older Adults

The evidence for older adults is particularly weak 4. Doses studied range from 0.5-10 mg with inconsistent results.

Practical approach:

• Starting dose: 1-2 mg
• Maximum studied dose: 6 mg
• Timing: 1-2 hours before desired bedtime
• Caveat: Aging reduces responsiveness to melatonin due to decreased melatonin receptor functional potency 5

Critical warning for dementia patients: The American Academy of Sleep Medicine suggests AGAINST using melatonin for irregular sleep-wake rhythm disorder (ISWRD) in older people with dementia (WEAK AGAINST recommendation) 1, 6. Studies in Alzheimer's patients showed no significant benefit with 2.5 mg, only trends with 10 mg 6.

Formulation Matters

• Fast-release (immediate-release): Preferred for sleep onset problems and circadian phase shifting 1
• Controlled-release: Less evidence for efficacy; one study showed no additional benefit with dose escalation 1

Safety Profile

Short-term safety is well-established across all age groups 1. Common mild adverse effects include:

• Morning drowsiness (28.8%) 7
• Headache (25.1%) 7
• Loose stools (rare) 3

Long-term safety concerns:

• Rigorous long-term data are lacking, particularly in children 1
• Benefits/harms assessment remains uncertain 1
• Studies up to 3.8 years in children with neurodevelopmental disabilities showed continued benefit without serious adverse effects 1
• No evidence of dependence even at high doses 8

What NOT to Use Melatonin For

The American Academy of Sleep Medicine recommends AGAINST melatonin for chronic insomnia in adults (WEAK AGAINST, based on 2 mg dose trials) 9. For primary insomnia without circadian component, other agents are preferred.

Critical Clinical Pearls

1. Melatonin is NOT a sedative - it works by shifting circadian phase, requiring proper timing 1.5-3 hours before desired sleep
2. Dose-response is non-linear - more is not necessarily better; optimal appears to be 4-5 mg 2
3. Quality control is absent - as a dietary supplement in the U.S., actual melatonin content varies widely from labeled amounts 10, 11
4. Informed consent is essential - particularly for pediatric use given limited long-term safety data 1
5. Combine with behavioral interventions - melatonin alone is insufficient; sleep hygiene and light exposure timing are critical 12, 6